WWW.JNEUROSCI.ORG
-
The Journal of Neuroscience Synaptic Systems Antibody Company
 QUICK SEARCH:   [advanced]


     
-


HOME
  |  
SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (14)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Weinshenker, D.
Right arrow Articles by Palmiter, R. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Weinshenker, D.
Right arrow Articles by Palmiter, R. D.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*Seizures

 Previous Article  |  Next Article 

The Journal of Neuroscience, October 1, 2001, 21(19):7764-7769

Genetic Comparison of Seizure Control by Norepinephrine and Neuropeptide Y

David Weinshenker1, 2, Patricia Szot3, 4, Nicole S. Miller1, 2, Nicole C. Rust1, 2, John G. Hohmann5, Ujwal Pyati2, Sylvia S. White3, 4, and Richard D. Palmiter1, 2

Departments of 1 Howard Hughes Medical Institute, 2 Biochemistry, 3 Psychiatry and Behavioral Science, 4 Geriatric Research, Education, and Clinical Center, and 5 Program for Neurobiology and Behavior, University of Washington, Seattle, Washington 98195

Epilepsy is a disease of neuronal hyperexcitability, and pharmacological and genetic studies have identified norepinephrine (NE) and neuropeptide Y (NPY) as important endogenous regulators of neuronal excitability. Both transmitters signal through G-protein-coupled receptors, are expressed either together or separately, and are abundant in brain regions implicated in seizure generation. NPY knock-out (NPY KO) and dopamine beta -hydroxylase knock-out (DBH KO) mice that lack NE are susceptible to seizures, and agonists of NE and NPY receptors protect against seizures. To examine the relative contributions of NE and NPY to neuronal excitability, we tested Dbh;Npy double knock-out (DKO) mice for seizure sensitivity. In general, DBH KO mice were much more seizure-sensitive than NPY KO mice and had normal NPY expression, demonstrating that an NPY deficiency did not contribute to the DBH KO seizure phenotype. DKO mice were only slightly more sensitive than DBH KO mice to seizures induced by kainic acid, pentylenetetrazole, or flurothyl, although DKO mice were uniquely prone to handling-induced seizures. NPY contributed to the seizure phenotype of DKO mice at high doses of convulsant agents and advanced stages of seizures. These data suggest that NE is a more potent endogenous anticonvulsant than NPY, and that NPY has the greatest contribution under conditions of extreme neuronal excitability.

Key words: norepinephrine; NPY; dopamine beta -hydroxylase; mice; epilepsy; seizure; pentylenetetrazole; flurothyl; kainic acid; mice; knock-out; in situ hybridization; neurotransmitter


Copyright © 2001 Society for Neuroscience  0270-6474/01/21197764-06$05.00/0


This article has been cited by other articles:


Home page
J Child NeurolHome page
K. Aydin, A. Serdaroglu, C. Okuyaz, A. Bideci, and K. Gucuyener
Serum Insulin, Leptin, and Neuropeptide Y Levels in Epileptic Children Treated With Valproate
J Child Neurol, October 1, 2005; 20(10): 848 - 851.
[Abstract] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. F. Cryan, O. F. O'Leary, S.-H. Jin, J. C. Friedland, M. Ouyang, B. R. Hirsch, M. E. Page, A. Dalvi, S. A. Thomas, and I. Lucki
Norepinephrine-deficient mice lack responses to antidepressant drugs, including selective serotonin reuptake inhibitors
PNAS, May 25, 2004; 101(21): 8186 - 8191.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
C. Richichi, E.-J. D. Lin, D. Stefanin, D. Colella, T. Ravizza, G. Grignaschi, P. Veglianese, G. Sperk, M. J. During, and A. Vezzani
Anticonvulsant and Antiepileptogenic Effects Mediated by Adeno-Associated Virus Vector Neuropeptide Y Expression in the Rat Hippocampus
J. Neurosci., March 24, 2004; 24(12): 3051 - 3059.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
G. Bregola, S. Zucchini, D. Rodi, A. Binaschi, C. D'Addario, D. Landuzzi, R. Reinscheid, S. Candeletti, P. Romualdi, and M. Simonato
Involvement of the Neuropeptide Nociceptin/Orphanin FQ in Kainate Seizures
J. Neurosci., November 15, 2002; 22(22): 10030 - 10038.
[Abstract] [Full Text] [PDF]



-

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help

-
Copyright 2008 by Society for Neuroscience ONLINE ISSN: 1529-2401
-